Latest Share Chat

REMOVE ADS

Skinbiotherap. Share News (SBTX)

Skinbiotherap. Information

Share Price Information for Skinbiotherap. (SBTX)

Share Price is delayed by 15 minutes

Get Live Data

11.50 0.50 (4.55%)

Bid:

11.00

Ask:

12.00

Spread: 1.00 (9.091%)

Market Cap: £29.80m

Last checked at -

Intraday Skinbiotherap. Share Chart

REMOVE ADS

Skinbiotherap. News

SkinBioTherapeutics Raises GBP1.5 Million In Private Placing (ALLISS)

LONDON (Alliance News) - SkinBioTherapeutics PLC said on Monday it has raised GBP1.5 million through a share placing, for exploring new opportunities ...

SkinBioTherapeutics Loss Widens As It Targets Commercialisation

LONDON (Alliance News) - SkinBioTherapeutics PLC on Thursday reported a widened interim loss on the back of higher research costs as it looks to advan...

SkinBio seeking 'commercially experienced' CEO as business evolves

(Sharecast News) - SkinBioTherapeutics on Thursday announced that it is seeking a "commercially experienced" replacement for Cath O'Neill, as she tran...

SkinBioTherapeutics Starts Final Phases In SkinBiotix In Human Study

LONDON (Alliance News) - SkinBioTherapeutics PLC said Tuesday it started the final phase of its in-human study of its SkinBiotix technology.The life s...

SkinBioTherapeutics Completes First Two Human Studies Of SkinBiotix

LONDON (Alliance News) - Skin health-focused life science company SkinBioTherapeutics PLC on Wednesday reported positive results from the first two pa...

SkinBioTherapeutics Annual Loss Widens On Increased Research Costs

LONDON (Alliance News) - SkinBioTherapeutics PLC on Thursday reported a widened annual loss mainly due to costs incurred in preparation of a human stu...

Skinbio begins human studies of moisturising cream

(Sharecast News) - The past year has seen SkinBioTherapeutics make "significant progress" with the development of its moisturising cream and efforts t...

OptiBiotix Health To Separate Probiotic Division For Potential Listing

LONDON (Alliance News) - OptiBiotix Health PLC on Monday said it intends to form a subsidiary ProBiotix Health Ltd and appoint Adam Reynolds as non-ex...